# Correction: Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma

**Authors:** Zhuoran Wang, Cunzhen Zhang, Jianhua Yin, Nan Li

PMC · DOI: 10.3389/fimmu.2025.1647890 · 2025-06-30

## Full-text entities

- **Diseases:** hepatocellular carcinoma (MESH:D006528), BCLC stage B and C (MESH:D019694)

---
Source: https://tomesphere.com/paper/PMC12257976